Načítá se...

Cost-effectiveness of oxaliplatin in the adjuvant treatment of colon cancer in Canada

OBJECTIVE: The cost-effectiveness of oxaliplatin in combination with 5-fluorouracil/leucovorin (5fu/lv)—the folfox regimen—was compared with that of 5fu/lv alone as adjuvant therapy for patients with stage iii colon cancer, from the perspective of the Cancer Care Ontario New Drug Funding Program. In...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Attard, C.L., Maroun, J.A., Alloul, K., Grima, D.T., Bernard, L.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Multimed Inc. 2010
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826771/
https://ncbi.nlm.nih.gov/pubmed/20179799
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!